" class="no-js "lang="en-US"> Home - Medtech Alert
Saturday, February 04, 2023

Top Posts

NHS To Offer Licensed Cannabis-Based Medicine To Treat Rare Genetic Condition

The NHS will be able to prescribe cannabidiol (Cannabis) to patients with a rare, seizure-causing […]

Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer

Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first-in-class therapeutics for highly aggressive cancers, […]

Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials

Personalis, a leader in advanced genomics for precision oncology, and Moderna, a biotechnology company pioneering […]

Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe

Trelleborg Healthcare & Medical announces a substantial investment to expand its European biopharmaceutical manufacturing capabilities […]

Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch

Revive Therapeutics, a specialty life sciences company focused on the research and development of therapeutics […]

Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest

Accenture has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions […]

enGene Appoints Alex Nichols, PhD as President and Chief Operating Officer

enGene, a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal […]

Orexo Submits New Drug Application to FDA for OX124, a High-dose Rescue Medication for Opioid Overdose

Orexo AB announces the submission of a New Drug Application (NDA) to the US Food and […]

Abbott Announces US and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms

Abbott has announced two approvals as part of its growing suite of electrophysiology products in […]

RefleXion Receives FDA Clearance for Biology-Guided Radiotherapy Treatment for Early and Late-stage Cancers

RefleXion Medical, a therapeutic oncology company, today announced the US Food and Drug Administration (FDA) […]

Cardiff Oncology Announces the Appointment of Fairooz Kabbinavar, MD, FACP, as Chief Medical Officer

Cardiff Oncology, a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to […]

iCRYO Announces Partnership with Therapeutic Manufacturer, BTL

iCRYO, the fast-growing recovery and wellness brand that focuses on a series of health-related recovery […]

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MMP7 for Treatment of Idiopathic Pulmonary Fibrosis

Arrowhead Pharmaceuticals announced today that it has dosed the first subjects in a Phase 1/2a […]

  1. Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer Read more
  2. Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials Read more
  3. Trelleborg to Expand its BioPharmaceutical Manufacturing Footprint in Europe Read more
  4. Revive Therapeutics Enters into Research Collaboration Agreement with PharmaTher for Development of MDMA Transdermal Patch Read more
  5. Accenture Expands Strategy Capabilities in Life Sciences with the Acquisition of Bionest Read more